Quantitative 7T phase imaging in premanifest huntington disease

American Journal of Neuroradiology

Volumn 35, Issue 9, 2014, Pages 1707-1713

  Apple, A C ^a   Possin, K L ^a   Satris, G ^a   Johnson, E ^a   Lupo, J M ^a   Jakary, A ^a   Wong, K ^a   Kelley, D A C ^b   Kang, G A ^a   Sha, S J ^a   Kramer, J H ^a   Geschwind, M D ^a   Nelson, S J ^a   Hess, Christopher P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b GE HEALTHCARE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ARTICLE; BRAIN SIZE; CAUDATE NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC IMAGING; EVALUATION STUDY; EXECUTIVE FUNCTION; FEMALE; HOSPITAL; HUMAN; HUNTINGTON CHOREA; IMAGE PROCESSING; LIMB; MALE; MEASUREMENT ACCURACY; MONITORING; NERVE DEGENERATION; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PREMANIFEST HUNTINGTON DISEASE; QUANTITATIVE DIAGNOSIS; UNIFIED HUNTINGTON DISEASE RATING SCALE; UNITED STATES; WORKING MEMORY; AGED; COMPUTER ASSISTED DIAGNOSIS; GENETICS; METABOLISM; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PATHOLOGY; PROCEDURES;

IRON;

ADULT; AGED; CAUDATE NUCLEUS; FEMALE; HUMANS; HUNTINGTON DISEASE; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IRON; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS;

EID: 84907100770     PISSN: 01956108     EISSN: 1936959X     Source Type: Journal    
DOI: 10.3174/ajnr.A3932     Document Type: Article

References (40)

1. Vonsattel JP, DiFiglia M. Huntington disease. J Neuropathol Exp Neurol 1998;57:369-84
2. Li SH, Li XJ. Huntingtin and its role in neuronal degeneration. Neuroscientist 2004;10:467-75
3. Bohanna I, Georgiou-Karistianis N, Hannan AJ, et al. Magnetic resonance imaging as an approach towards identifying neuropathological biomarkers for Huntington's disease. Brain Res Rev 2008;58:209-25
4. Aylward EH, Codori AM, Rosenblatt A, et al. Rate of caudate atrophy in presymptomatic and symptomatic stages of Huntington's disease. Mov Disord 2000;15:552-60
5. Rosas HD, Goodman J, Chen YI, et al. Striatal volume loss in HD as measured by MRI and the influence of CAG repeat. Neurology 2001;57:1025-28
6. Kipps CM, Duggins AJ, Mahant N, et al. Progression of structural neuropathology in preclinical Huntington's disease: a tensor based morphometry study. J Neurol Neurosurg Psychiatry 2005;76:650-55
7. Tabrizi SJ, Langbehn DR, Leavitt BR, et al. Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data. Lancet Neurol 2009;8:791-801
8. Weir DW, Sturrock A, Leavitt BR. Development of biomarkers for Huntington's disease. Lancet Neurol 2011;10:573-90
9. Rosas HD, Salat DH, Lee SY, et al. Cerebral cortex and the clinical expression of Huntington's disease: complexity and heterogeneity. Brain 2008;131:1057-68
10. Dexter DT, Carayon A, Javoy-Agid F, et al. Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. Brain 1991;114:1953-75
11. Bartzokis G, Lu PH, Tishler TA, et al. Myelin breakdown and iron changes in Huntington's disease: pathogenesis and treatment implications. Neurochem Res 2007;32:1655-64
12. Bartzokis G, Tishler TA. MRI evaluation of basal ganglia ferritin iron and neurotoxicity in Alzheimer's and Huntingon's disease. Cell Mol Biol (Noisy-le-Grand) 2000;46:821-33
13. Bartzokis G, Cummings J, Perlman S, et al. Increased basal ganglia iron levels in Huntington disease. Arch Neurol 1999;56:569-74
14. Chen JC, Hardy PA, Kucharczyk W, et al. MRof human postmortem brain tissue: correlative study between T2 and assays of iron and ferritin in Parkinson and Huntington disease. AJNR Am J Neuroradiol 1993;14:275-81
15. Dumas EM, Versluis MJ, van den Bogaard SJ, et al. Elevated brain iron is independent from atrophy in Huntington's disease. Neuroimage 2012;61:558-64
16. Haacke EM, Mittal S, Wu Z, et al. Susceptibility-weighted imaging: technical aspects and clinical applications, part 1. AJNR Am J Neuroradiol 2009;30:19-30
17. Haacke EM, Cheng NY, House MJ, et al. Imaging iron stores in the brain using magnetic resonance imaging. Magn Reson Imaging 2005;23:1-25
18. Haacke EM, Gollapalli L, Rosas DH, et al. Using SWI as a means to better visualize the caudate nucleus in Huntington's disease. In: Proceedings of 14th Annual Meeting of the International Society for Magnetic Resonance in Medicine; Seattle, Washington. May 6-12, 2006:2657
19. Haacke EM, Ayaz M, Khan A, et al. Establishing a baseline phase behavior in magnetic resonance imaging to determine normal vs. abnormal iron content in the brain. J Magn Reson Imaging 2007;26:256-64
20. Hammond KE, Metcalf M, Carvajal L, et al. Quantitative in vivo magnetic resonance imaging of multiple sclerosis at 7 Tesla with sensitivity to iron. Ann Neurol 2008;64:707-13
21. Abduljalil AM, Schmalbrock P, Novak V, et al. Enhanced gray and white matter contrast of phase susceptibility-weighted images in ultra-high-field magnetic resonance imaging. J Magn Reson Imaging 2003;18:284-90
22. 2∗-weighted MR images of the brain: application to Huntington's disease. J Magn Reson Imaging 2014;39:633-40
23. Paulsen JS, Hayden M, Stout JC, et al. Preparing for preventive clinical trials: the Predict-HD study. Arch Neurol 2006;63:883-90
24. Harrington DL, Smith MM, Zhang Y, et al. Cognitive domains that predict time to diagnosis in prodromal Huntington disease. J Neurol Neurosurg Psychiatry 2012;83:612-19
25. Zhang Y, Long JD, Mills JA, et al. Indexing disease progression at study entry with individuals at-risk for Huntington disease. Am J Med Genet B Neuropsychiatr Genet 2011;156B:751-63
26. Paulsen JS, Langbehn DR, Stout JC, et al. Detection of Hutington's disease decades before diagnosis: the PREDICT-HD study. J Neurol Neurosurg Psychiatry 2008;79:874-80
27. Duff K, Paulsen JS, Beglinger LJ, et al. "Frontal" behaviors before the diagnosis of Huntington's disease and their relationship to markers of disease progression: evidence of early lack of awareness. J Neuropsychiatry Clin Neurosci 2010;22:196-207
28. Hart E, Middelkoop H, Jurgens CK, et al. Seven-year clinical follow-up of premanifest carriers of Huntington's disease. PLoS Curr 2011;3:RRN1288
29. Stout JC, Paulsen JS, Queller S, et al. Neurocognitive signs in prodromal Huntington disease. Neuropsychology 2011;25:1-14
30. You SC, Geschwind MD, Sha SJ, et al. Executive functions in premanifest Huntington's disease. Mov Disord 2014;29(suppl 3):405-09
31. Hammond KE, Lupo JM, Xu D, et al. Development of a robust method for generating 7.0 T multichannel phase images of the brain with application to normal volunteers and patients with neurological diseases. Neuroimage 2008;39:1682-92
32. Patenaude B, Smith SM, Kennedy DN, et al. A Bayesian model of shape and appearance for subcortical brain segmentation. Neuroimage 2011;56:907-22
33. Jenkinson M, Bannister P, Brady M, et al. Improved optimization for the robust and accurate linear registration and motion correction of brain images. Neuroimage 2002;17:825-41
34. Buckner RL, Head D, Parker J, et al. A unified approach for morphometric and functional data analysis in young, old, and demented adults using automated atlas-based head size normalization: reliability and validation against manual measurement of total intracranial volume. Neuroimage 2004;23:724-38
35. You C, Satris G, Apple A, et al. New sensitive measures of executive functioning in premotor Huntington's disease. Neurology 2013;80:S20.002
36. He X, Yablonskiy DA. Biophysical mechanisms of phase contrast in gradient echo MRI. Proc Natl Acad Sci U S A 2009;106:13558-63
37. Bilgic B, Pfefferbaum A, Rohlfing T, et al. MRI estimates of brain iron concentration in normal aging using quantitative susceptibility mapping. Neuroimage 2012;59:2625-35
38. Hagemeier J, Dwyer MG, Bergsland N, et al. Effect of age on MRI phase behavior in the subcortical deep gray matter of healthy individuals. AJNR Am J Neuroradiol 2013;34:2144-51
39. Murphy DG, DeCarli C, Schapiro MB, et al. Age-related differences in volumes of subcortical nuclei, brain matter and cerebrospinal fluid in healthy men as measured with magnetic resonance imaging. Arch Neurol 1992;49:839-45
40. Berg D, Youdim MB. Role of iron in neurodegenerative disorders. Top Magn Reson Imaging 2006;17:5-17